Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Rocuronium Bromide for Non Melanoma Skin Cancer Prevention
Bode, A. M. (PI), Gurvich, V. J. (CoI), Schumacher, R. J. (CoI), Zhang, T. (CoI) & Verma, V. (Other Role)
12/1/23 → 11/30/25
Project: Research project
-
Effect of maternal obesity on breast cancer among offspring: role of the gut microbiota
Hilakivi-Clarke, L. (PI), De Oliveira Andrade, F. (CoI), Jin, L. (CoI), Staley, C. (CoI), Verma, V. (CoI) & Yadav, S. (Other Role)
7/15/23 → 6/30/28
Project: Research project
-
Targeting T cell exhaustion via mitochondrial reorganization for enhanced immunotherapy of melanoma
Verma, V. (PI)
7/1/23 → 6/30/26
Project: Research project
-
TEPP46 mediated enhancement of checkpoint blockade therapy in solid cancers
Verma, V. (PI)
11/8/24 → 11/7/25
Project: Research project
-
Dopamine D2 receptor agonists abrogate neuroendocrine tumour angiogenesis to inhibit chemotherapy-refractory small cell lung cancer progression
Alam, S. K., Pandit, A., Wang, L., Mortazavi Farsani, S. S., Thiele, B. A., Manoj, P., Aubry, M. C., Verma, V., Rudin, C. M., Lo, Y. C. & Hoeppner, L. H., Dec 2025, In: Cell Death and Disease. 16, 1, 370.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Pyruvate kinase M2 activation reprograms mitochondria in CD8 T cells, enhancing effector functions and efficacy of anti-PD1 therapy
Mortazavi Farsani, S. S., Soni, J., Jin, L., Yadav, A. K., Bansal, S., Mi, T., Hilakivi-Clarke, L., Clarke, R., Youngblood, B., Cheema, A. & Verma, V., Jun 3 2025, In: Cell Metabolism. 37, 6, p. 1294-1310.e7Research output: Contribution to journal › Article › peer-review
10 Scopus citations -
Lactate mediated metabolic crosstalk between cancer and immune cells and its therapeutic implications
Mortazavi Farsani, S. S. & Verma, V., 2023, In: Frontiers in Oncology. 13, 1175532.Research output: Contribution to journal › Review article › peer-review
Open Access16 Scopus citations -
Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies
Anderson, K. G., Braun, D. A., Buqué, A., Gitto, S. B., Guerriero, J. L., Horton, B., Keenan, B. P., Kim, T. S., Overacre-Delgoffe, A., Ruella, M., Triplett, T. A., Veeranki, O., Verma, V. & Zhang, F., Jun 30 2023, In: Journal for ImmunoTherapy of Cancer. 11, 6, 006533.Research output: Contribution to journal › Article › peer-review
Open Access14 Scopus citations -
An all-in-one adjuvanted therapeutic cancer vaccine targeting dendritic cell cytosol induces long-lived tumor suppression through NLRC4 inflammasome activation
Puth, S., Verma, V., Hong, S. H., Tan, W., Lee, S. E. & Rhee, J. H., Jul 2022, In: Biomaterials. 286, 121542.Research output: Contribution to journal › Article › peer-review
Open Access16 Scopus citations